Skip to main content
DIRECTA PLUS PLC logo

DIRECTA PLUS PLC — Investor Relations & Filings

Ticker · DCTA ISIN · GB00BSM98843 LEI · 213800X2DQST3K5ND898 IL Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2022-10-17 Board/Management Inform…
Country GB United Kingdom
Listing IL DCTA

About DIRECTA PLUS PLC

https://www.directa-plus.com/

Directa Plus PLC is a producer and supplier of engineered graphene nanoplatelets-based products. The company has developed a proprietary, patented, and chemical-free manufacturing process that is scalable and sustainable, designed to meet the quality and volume requirements of large industrial supply chains. Its core product, G+® Graphene Plus, is a material used to enhance the performance of commercial and industrial products. Key applications include performance textiles and sportswear featuring its Planar Thermal Circuit® technology for thermal regulation, Grafysorber® for environmental remediation such as oil absorption, and Gipave®, a supermodifier for enhancing asphalt durability. The company's materials are also used in composites, footwear, and antimicrobial surfaces.

Recent filings

Filing Released Lang Actions
Board Changes
Board/Management Information Classification · 1% confidence The document is an official announcement released via RNS (Regulatory News Service) on October 17, 2022. The primary subject is the 'Appointment of Non-Executive Director' (General Wesley K. Clark) and the stepping down of another director (David Gann). This content directly corresponds to the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing or a report announcement, but a specific corporate action announcement regarding management changes.
2022-10-17 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1935 characters) and contains the header 'RNS Number : 1841B' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific, immediate operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard shareholder communication (like DEF 14A or AGM-R). Since it is a direct, non-standard regulatory announcement distributed via the RNS system, and it doesn't fit into the more specific categories like DIRS, DIV, or DLST, the most appropriate classification is the general regulatory announcement fallback category.
2022-09-29 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1918 characters) and contains the header 'RNS Number : 1832B'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or CAP), the most appropriate classification is the general Regulatory Filings fallback category.
2022-09-29 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half Year Report' for the period ended 30 June 2022, issued by Directa Plus PLC. It contains detailed financial highlights (revenue, EBITDA, cash position), operational reviews, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2022
2022-09-29 English
Trading Statement
Earnings Release Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 8490X) on September 1, 2022. The title is "Trading Update and Notice of Results." It provides unaudited financial highlights for the six months to June 30, 2022 (H1 2022), including revenue figures, and announces the date for the full half-year results (September 29, 2022). This structure—a brief update on performance ahead of a formal report release—is characteristic of an Earnings Release (ER). It is not the full comprehensive report (IR) nor is it a general regulatory filing (RNS) because it has a specific financial reporting purpose. It is too detailed to be just a Report Publication Announcement (RPA), as it contains substantive trading commentary and preliminary figures. H1 2022
2022-09-01 English
US Patent Notice
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains an announcement dated August 30, 2022. The content details the receipt of a 'Notice of Allowance for US Patent' regarding the company's G+® embedded polyurethane membrane. This is a specific corporate update concerning intellectual property (IP) and patent status, not a full financial report (like 10-K or IR), an earnings release (ER), or a general meeting material (AGM-R/DEF 14A). Since it is a specific, non-financial regulatory announcement distributed via RNS, and it doesn't fit the definitions for DIRS, DIV, CAP, or MANG, the most appropriate classification is the general regulatory announcement category, RNS, as it is a formal notification to the market via the RNS system about a material event (patent allowance). Although it relates to IP, there is no specific 'IP' code for patent updates, making RNS the best fit for a general regulatory filing/announcement.
2022-08-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.